870838-55-4

Upstream product

• 59557-91-4 4-bromo-2-methoxyaniline 
• 870838-52-1 o-bromotrifluoroacetanilide 
• 870838-53-2 1-{[4-bromo-2-(methyloxy)phenyl]amino}-2-propanone 

Downstream Products

• 870838-56-5 1-(4-bromo-2-methoxyphenyl)-4-methyl-1H-imidazole 
• 870838-57-6 1-(4-iodine-2-methoxyphenyl)-4-methyl-1H-imidazole 
• 870838-58-7 tert-butyl [3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]propiolic acid ester 

Relevant academic research and scientific papers

Cinnamide compound

The present invention relates to a compound represented by Formula (I): (wherein Ar1 represents an imidazolyl group which may be substituted with 1 to 3 substituents; Ar2 represents a pyridinyl group, a pyrimidinyl group, or a phenyl group which may be substituted with 1 to 3 substituents; X1 represents (1) —C≡C— or (2) a double bond etc. which may be substituted; R1 and R2 represent, for example, a C1-6 alkyl group or C3-8 cycloalkyl group which may be substituted) or a pharmacologically acceptable salt thereof and to the use thereof as pharmaceutical agents. The object of the present invention is to find a therapeutic or preventive agent for diseases caused by Aβ. According to the present invention, a therapeutic or preventive agents for diseases caused by Aβ can be provided.